Clinical Trial Update: Donor-Derived Viral Specific T-cells (VSTs) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating donor-derived viral-specific T-cells (VSTs) to prevent or treat viral infections in allogeneic stem cell transplant recipien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Viral Infection

Drugs mentioned

• Donor-Derived Viral Specific T-cells (VSTs) (Viral-specific T-cells)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Allogeneic Stem Cell Transplant, Viral Infection | Phase 1, Phase 2 | Status: RECRUITING